HIT Consultant November 5, 2020
Ram Sathia, VP of Intelligent Automation at PK 1

While most of the public’s attention is focused on the horse race for an approved COVID-19 vaccine, another major hurdle lies just around the corner: the distribution of hundreds of millions of vaccine doses. In today’s highly complex and disconnected health data landscape, technologies like AI, Machine Learning, and robotic process automation (RPA) will be essential to making sure that the highest-risk patients receive the vaccine first.

Why identifying at-risk patients is incredibly difficult

Once a vaccine is approved, it will take months or years to produce and distribute enough doses for the U.S.’ 330 million residents. Hospital systems, primary care physicians (PCPs), and provider networks will inevitably need to prioritize administration to at-risk patients, potentially focusing on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Robotics/RPA, Technology
Amazing Technologies Changing The Future Of Dermatology - 2
Humanoids: Transforming Industries And Leading The Future Of Robotics
Surgery's future gold standard
Nvidia advances robot learning and humanoid development with AI and simulation tools
AI Startup Lands $400 Million to Make Robots Handle Objects More Like Humans

Share This Article